Carles Barceló

1.6k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Carles Barceló is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Carles Barceló has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Carles Barceló's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and RNA modifications and cancer (2 papers). Carles Barceló is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and RNA modifications and cancer (2 papers). Carles Barceló collaborates with scholars based in Spain, Greece and United States. Carles Barceló's co-authors include Daniel Byrom, Sergio Palomo‐Ponce, Antoni Riéra, Elisa Espinet, Clara Morral, Mar Iglesias, Marta Sevillano, Xavier Hernando‐Momblona, Eduard Batlle and Carme Cortina and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Carles Barceló

15 papers receiving 1.2k citations

Hit Papers

Stromal gene expression defines poor-prognosis subtypes i... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carles Barceló Spain 10 640 616 300 184 144 17 1.2k
Woondong Jeong United States 9 974 1.5× 732 1.2× 402 1.3× 119 0.6× 126 0.9× 23 1.5k
Da‐Liang Ou Taiwan 20 656 1.0× 508 0.8× 320 1.1× 187 1.0× 300 2.1× 53 1.3k
Stacey M. Bagby United States 21 568 0.9× 516 0.8× 242 0.8× 94 0.5× 194 1.3× 62 1.1k
Miriam Redrado Spain 20 544 0.8× 518 0.8× 270 0.9× 80 0.4× 233 1.6× 39 1.1k
Ashwini A. Katre United States 16 802 1.3× 685 1.1× 350 1.2× 98 0.5× 135 0.9× 31 1.3k
Simonetta Buglioni Italy 22 930 1.5× 772 1.3× 511 1.7× 173 0.9× 188 1.3× 71 1.7k
Sauveur-Michel Maira Switzerland 8 952 1.5× 343 0.6× 310 1.0× 158 0.9× 112 0.8× 8 1.2k
Shuangbing Xu China 21 775 1.2× 370 0.6× 317 1.1× 68 0.4× 142 1.0× 42 1.1k
Hans Kristian Moen Vollan Norway 18 705 1.1× 466 0.8× 573 1.9× 97 0.5× 80 0.6× 25 1.3k

Countries citing papers authored by Carles Barceló

Since Specialization
Citations

This map shows the geographic impact of Carles Barceló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Barceló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Barceló more than expected).

Fields of papers citing papers by Carles Barceló

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carles Barceló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Barceló. The network helps show where Carles Barceló may publish in the future.

Co-authorship network of co-authors of Carles Barceló

This figure shows the co-authorship network connecting the top 25 collaborators of Carles Barceló. A scholar is included among the top collaborators of Carles Barceló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carles Barceló. Carles Barceló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Farré, Xavier, Natàlia Blay, Susana Iraola‐Guzmán, et al.. (2025). VEGFA sex-specific signature is associated to long COVID symptom persistence. BMC Medicine. 23(1). 552–552.
2.
Heller, Sandra, Thomas F.E. Barth, Patricia Gallego, et al.. (2025). Host factor PLAC8 is required for pancreas infection by SARS-CoV-2. Communications Medicine. 5(1). 34–34.
3.
Rubio‐Tomás, Teresa, et al.. (2024). Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences. 25(5). 2860–2860. 4 indexed citations
4.
González‐Moreno, Juan, Adrián Rodríguez, Sandra García, et al.. (2024). Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv). Scientific Reports. 14(1). 581–581. 9 indexed citations
5.
Torrens‐Mas, Margalida, Catalina Crespı́, Aina M. Galmés‐Panades, et al.. (2022). GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Frontiers in Cellular and Infection Microbiology. 12. 942951–942951. 5 indexed citations
6.
Rubio‐Tomás, Teresa, et al.. (2022). Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota. Frontiers in Oncology. 12. 995357–995357. 5 indexed citations
7.
Ugalde, Alejandro P., Gabriel Bretones, David Rodrı́guez, et al.. (2022). Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS‐CoV ‐2 entry into human cells. The EMBO Journal. 41(21). e110727–e110727. 17 indexed citations
8.
Barceló, Carles, et al.. (2022). The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update. Biomolecules. 12(3). 462–462. 18 indexed citations
9.
Barceló, Carles, et al.. (2022). Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. SHILAP Revista de lepidopterología. 2(3). 214–237. 4 indexed citations
10.
Brun, Sònia, M. Morell, Carles Barceló, et al.. (2021). KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer. Oncogene. 40(38). 5730–5740. 8 indexed citations
11.
Torrens‐Mas, Margalida, et al.. (2021). Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids. International Journal of Molecular Sciences. 22(19). 10547–10547. 18 indexed citations
12.
Calon, Alexandre, Enza Lonardo, Antonio Berenguer, et al.. (2015). Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nature Genetics. 47(4). 320–329. 775 indexed citations breakdown →
13.
Barceló, Carles, Julia Etchin, Marc R. Mansour, et al.. (2014). Ribonucleoprotein HNRNPA2B1 Interacts With and Regulates Oncogenic KRAS in Pancreatic Ductal Adenocarcinoma Cells. Gastroenterology. 147(4). 882–892.e8. 51 indexed citations
14.
Barceló, Carles, M. Morell, Blanca Alvarez-Moya, et al.. (2013). Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth. Cancer Research. 74(4). 1190–1199. 50 indexed citations
15.
Barceló, Carles, Alison J. Beckett, Blanca Alvarez-Moya, et al.. (2013). Oncogenic K-Ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status. Journal of Cell Science. 126(Pt 20). 4553–9. 29 indexed citations
16.
Etchin, Julia, Qingxiang Sun, Alex Kentsis, et al.. (2012). Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia. 27(1). 66–74. 145 indexed citations
17.
Alvarez-Moya, Blanca, Carles Barceló, Francesc Tebar, Montserrat Jaumot, & Neus Agell. (2011). CaM interaction and Ser181 phosphorylation as new K-Ras signaling modulators. Small GTPases. 2(2). 99–103. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026